Healthcare IT & Genomics
Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.
Analyst Insights
Signify Premium Insight: Oracle and Ferrum: Imaging AI in the Cloud
Signify Premium Insights Subscription Required
September 26th 2023 – Oracle has looked to extend its cloud capabilities to medical imaging, with the addition of Ferrum’s AI platform to its Cloud Marketplace. The move offers opportunities for the hyperscaler, but will it help Oracle compete with its peers?
Signify Premium Insight: GE Looks to Avoid Missed Opportunities
Signify Premium Insights Subscription Required
September 21st 2023 – GE HealthCare, in partnership with Mass General Brigham, has developed an algorithm which seeks to help providers make their radiology departments run more efficiently. With providers looking to do more with less, such tools could be attractive, but do they also offer an opportunity for vendors?
How to Integrate AI into Digital Pathology
The clinical digital pathology (DP) market is now taking off, with a flood of new adopters expected over the next few years. Pathology departments face many challenges as they embrace this change, from sequestering additional budgets to altering workflows to accommodate new technologies. So many changes must be considered with this transition that often there […]
Sigify Premium Insight: The Cloud’s Formed, but Still no Rain
Signify Premium Insights Subscription Required
August 22nd 2023 – The use of public cloud in medical imaging is increasing. But as more providers consider adopting the technology, more barriers, limitations and challenges must be confronted.
Signify Premium Insight: The Possibilities of Private Equity and Independent Practices
Signify Premium Insights Subscription Required
August 10th 2023 – Private Equity is increasingly buying up independent outpatient sites in the US. This creates some significant opportunities for vendors, but there are also some sizable risks.